<dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
<cite id="ilis8"><option id="ilis8"></option></cite>
    1. <ul id="ilis8"></ul>
  1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
    歡迎光臨:萊耀標(biāo)準(zhǔn)品網(wǎng)!
    ?您的位置:對(duì)照品 > 對(duì)照品 > 對(duì)照藥材 >
    5-Desthiopropyl-5-hydroxy-ticagrelor
    產(chǎn)品基本信息
    產(chǎn)品編號(hào):D297505
    產(chǎn)品名稱(chēng):5-Desthiopropyl-5-hydroxy-ticagrelor
    產(chǎn)品CAS:1644461-81-3
    規(guī)格含量:10mg
    產(chǎn)品價(jià)格:面議
    聯(lián)系我們:
    產(chǎn)品詳細(xì)介紹
    標(biāo)準(zhǔn)品編號(hào): D297505
    名稱(chēng): 5-Desthiopropyl-5-hydroxy-ticagrelor
    別名: Ticagrelor Related Compound 15; (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-hydroxy-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
    CAS號(hào): 1644461-81-3
    分子式: C??H??F?N?O?
    分子量: 464.42
    種類(lèi): Standards; Pharmaceutical/API Drug Impurities/Metabolites;
    應(yīng)用: 5-Desthiopropyl-5-hydroxy-ticagrelor is a related compound of ticagrelor (T437700). Ticagrelor, the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS).
    參考文獻(xiàn)


    2011-2018 信陽(yáng)萊耀生物科技有限公司 @ 信陽(yáng)埃爾文生物科技有限公司版權(quán)所有

    中檢所標(biāo)準(zhǔn)品,對(duì)照品,標(biāo)準(zhǔn)氣體
    Keywords: 中檢所標(biāo)準(zhǔn)品 對(duì)照品 標(biāo)準(zhǔn)氣體
    <dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
    <cite id="ilis8"><option id="ilis8"></option></cite>
      1. <ul id="ilis8"></ul>
    1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
      刘亦菲一区二区三区免费看 | 中字幕精品一区二区三区 | 精品国产日本 | 海角社区国产精品 | 天天摸天天操视频 |